Reduced COPD Exacerbation Risk Correlates With Improved FEV(1): A Meta-Regression Analysis

BACKGROUND: The mechanism by which various classes of medication reduce COPD exacerbation risk remains unknown. We hypothesized a correlation between reduced exacerbation risk and improvement in airway patency as measured according to FEV(1). METHODS: By systematic review, COPD trials were identifie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chest
Hlavní autoři: Zider, Alexander D., Wang, Xiaoyan, Buhr, Russell G., Sirichana, Worawan, Barjaktarevic, Igor Z., Cooper, Christopher B.
Médium: Artigo
Jazyk:Inglês
Vydáno: American College of Chest Physicians 2017
Témata:
COPD
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026240/
https://ncbi.nlm.nih.gov/pubmed/28483609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.04.174
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky